CMPS
COMPASS Pathways Plc$8.74CS band Caution
−$3.15 (27.19%) At close $8.42 · Today
☾After Hours +$0.31 (3.70%) Nov 2, 4:45 PM ET
About CMPS
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.